Sangamo Therapeutics Company Profile

Aggregated data from the web about Sangamo Therapeutics

Company Name	Sangamo Therapeutics
Website	https://www.sangamo.com
Snippet	Sangamo Therapeutics Announces Strategic Update and Reports Preliminary First Quarter 2023 Financial Results Sangamo Therapeutics Announces Evidence of Clinical Benefit in Phase 1/2 STAAR Study in Fabry Disease Presentations All Presentations ASGCT 2023
Type	Public
Founded	1995
Revenue	$102 Million(2019)[1]
Website	sangamo.com
Industry	Biotechnology
Traded as	Nasdaq: SGMORussell 2000 Index component
Key people	Sandy Macrae (CEO)Edward Rebar (CTO)
Headquarters	Brisbane, California, US
Number of employees	354

Sangamo Therapeutics is part of the United States company list

Sangamo Therapeutics is part of the Biotechnology company list

Have a list of company names and need to update information? Use our Company Search tool.

Please note that Powrbot Inc does not own this content and cannot vouch for its accuracy, we simply aggregate public information for ease of research.

Want to update this profile? Please contact us here with a link to the public source verifying the edit.